Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-25-000010

CHIEF OPERATING OFFICER sold 8,000 shares at an average $86.22 ($689,790)

  • CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wassil Jim CHIEF OPERATING OFFICER 2025-02-03 Option exercise 10b5-1 +8,000 $2.42 $19,360 213,695 D: show line 1 in the form
Wassil Jim CHIEF OPERATING OFFICER 2025-02-03 Sale 10b5-1 −5,314 $86.00 $456,983 208,381 D: show line 2 in the form
Wassil Jim CHIEF OPERATING OFFICER 2025-02-03 Sale 10b5-1 −2,666 $86.67 $231,049 205,715 D: show line 3 in the form
Wassil Jim CHIEF OPERATING OFFICER 2025-02-03 Sale 10b5-1 −20 $87.94 $1,759 205,695 D: show line 4 in the form
Open-market sales · 8,000 sh · avg $86.22 · $689,790

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wassil Jim CHIEF OPERATING OFFICER 2025-02-03 Option exercise · Stock Option (right to buy) 10b5-1 −8,000 2,638 D: show line 5 in the form
Loading xslF345X05/wk-form4_1738714793.xml…